Heron Therapeutics, Inc.
HRTX· Nasdaq
HRTXHeron Therapeutics, Inc.
Filed Aug 4, 2014 · 10-Q · 35 days after period end · 0001193125-14-292999
| Metric | Q2 2014 | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|---|
| Net Income | -$19.01M | -$15.41M | -$4.57M | -$1.93M |
| EPS Diluted | -$0.78 | -$1.01 | -$0.46 | -$0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Heron Therapeutics, Inc. · CIK 818033 · Engraved from SEC EDGAR
ended Jun 30, 2014 · filed Aug 4, 2014 · 35 d after period end
